HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CUTIA-B

10.940

+0.6206.01%

Volume:922.00K

Turnover:9.98M

Market Cap:3.81B

PE:-7.09

High:11.120

Open:10.430

Low:10.360

Close:10.320

52wk High:18.260

52wk Low:3.640

Shares:348.00M

HK Float Shares:348.00M

Volume Ratio:1.27

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.544

ROE:-48.56%

ROA:-21.52%

PB:4.60

PE(LYR):-7.09

PS:13.91

Loading ...

Overview Company News Filings

CUTIA-B (02487) Shareholders Deposit Shares with Huatai Hong Kong Worth HK$286 Million

Cutia Therapeutics Completes Successful Private Placement of New Shares, Raising Funds from Key Investors

CUTIA-B (02487) Completes Placement of 28.904 Million Shares, Raising Net Proceeds of Approximately HK$240 Million

Hong Kong Stocks End in Green Friday as Earnings Flurry Continues; Cutia Therapeutics Seeking HK$240.3 Million via Share Sale

MT Newswires Live

HK Movers | Biotech Stocks Surge With Cutia Therapeutics up 14%

Tiger Newspress

Stock Track | Cutia Therapeutics Soars 5.34% Pre-market Following HK$240 Million Share Placing Announcement

CUTIA-B (02487) Plans to Issue 28.904 Million Placement Shares at 12.04% Discount, Raising Net Proceeds of HK$240 Million

Cutia Therapeutics - Placing of 28.9 Mln Shares in Aggregate at a Price of HK$8.40 per Share

THOMSON REUTERS

Cutia Therapeutics Announces Placing of 28.9 Million New Shares Under General Mandate

CUTIA-B (02487): Zhang Zhisong Appointed as Independent Non-Executive Director

CUTIA-B (02487): Liang Zhijie Appointed as Company Secretary

CUTIA-B (02487) Announces Interim Results with Net Loss of Approximately 239 Million Yuan, Up About 19.1% Year-over-Year

Cutia Therapeutics Announces Management Changes and Relocation of Hong Kong Office

Cutia Therapeutics Announces Management Changes: New Appointments to Nomination and Audit Committees as Mr. Tao Resigns

Cutia Therapeutics - Hy Revenue RMB66.3 Mln

THOMSON REUTERS

Cutia Therapeutics Gets Hong Kong Government Nod to Market Alopecia Drug; Shares Up 2%

MT Newswires Live

BRIEF-Cutia Therapeutics Says Cu-40102 Obtains Marketing Approval By Hong Kong Department Of Health

Cutia Therapeutics - Cu-40102 Obtains Marketing Approval by Hong Kong Department of Health

THOMSON REUTERS

Cutia Therapeutics Secures Regulatory Approval for CU-40102 Topical Finasteride Spray by China's National Medical Products Administration

Cutia Therapeutics' CU-30101 Marketing Authorization Application Accepted by National Medical Products Administration for Review

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02487/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02487","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02487\",,,,,undefined,":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"CUTIA-B","latestPrice":10.94,"timestamp":1757405293002,"preClose":10.32,"halted":0,"volume":922000,"delay":0,"floatShares":348000000,"shares":348000000,"eps":-1.5440633374223094,"marketStatus":"Not Yet Opened","change":0.62,"latestTime":"09-09 16:08:13","open":10.43,"high":11.12,"low":10.36,"amount":9977515,"amplitude":0.073643,"askPrice":10.94,"askSize":200,"bidPrice":10.85,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-1.680957136081125,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":0,"adr":0,"listingDate":1686499200000,"exchange":"SEHK","adjPreClose":10.32,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"volumeRatio":1.2740085671034131,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02487\",,,,,undefined,":{"symbol":"02487","floatShares":348000000,"roa":"-21.52%","roe":"-48.56%","lyrEps":-1.544063,"volumeRatio":1.2740085671034131,"shares":348000000,"dividePrice":0,"high":11.12,"amplitude":0.073643,"preClose":10.32,"low":10.36,"week52Low":3.64,"pbRate":"4.60","psRate":"13.91","week52High":18.26,"institutionHeld":0,"latestPrice":10.94,"committee":0.6,"eps":-1.5440633374223094,"divideRate":0,"volume":922000,"delay":0,"ttmEps":-1.680957136081125,"open":10.43,"prevYearClose":7.08,"prevWeekClose":10.5,"prevMonthClose":11.55,"prevQuarterClose":10.02,"fiveDayClose":10.46,"twentyDayClose":8.25,"sixtyDayClose":11.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02487\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-24","symbol":"02487","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2024-08-29","symbol":"02487","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724860800000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-27","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-29","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02487\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02487\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1744041600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02487\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02487","date":"2025-09-08","current":-6.964645,"percent":0.15343,"low":-15.485925,"twenty":-6.599039,"median":-3.214541,"eighty":-1.076426,"high":-0.826569,"avg":-4.209481,"sd":3.231673,"marketCap":3595183673},"quantilePoints":[{"date":"2023-06-16","current":-15.411162,"twenty":-14.413676,"median":-12.389874,"eighty":-12.075055,"marketCap":9394355968},{"date":"2023-06-23","current":-12.436662,"twenty":-14.898766,"median":-13.544522,"eighty":-12.376412,"marketCap":7539806732},{"date":"2023-06-30","current":-12.398371,"twenty":-14.32145,"median":-12.394122,"eighty":-11.447458,"marketCap":7448599392},{"date":"2023-07-07","current":-11.154992,"twenty":-13.792435,"median":-12.336647,"eighty":-11.411148,"marketCap":6688538230},{"date":"2023-07-14","current":-10.800615,"twenty":-12.879806,"median":-11.67313,"eighty":-11.073156,"marketCap":6566928444},{"date":"2023-07-21","current":-9.796084,"twenty":-12.413687,"median":-11.417592,"eighty":-10.790615,"marketCap":5928477067},{"date":"2023-07-28","current":-10.460353,"twenty":-12.393273,"median":-11.232297,"eighty":-10.42688,"marketCap":6323708872},{"date":"2023-08-04","current":-10.844647,"twenty":-12.36968,"median":-11.144468,"eighty":-10.471016,"marketCap":6566928444},{"date":"2023-08-11","current":-11.613111,"twenty":-12.376412,"median":-11.154992,"eighty":-10.495819,"marketCap":6992562695},{"date":"2023-08-18","current":-11.061159,"twenty":-12.34839,"median":-11.14973,"eighty":-10.533878,"marketCap":6612532113},{"date":"2023-08-25","current":-12.606042,"twenty":-12.421346,"median":-11.281516,"eighty":-10.611978,"marketCap":7539806732},{"date":"2023-09-01","current":-3.762061,"twenty":-12.421346,"median":-11.154992,"eighty":-10.467461,"marketCap":7904636090},{"date":"2023-09-08","current":-3.045502,"twenty":-12.394972,"median":-11.061159,"eighty":-10.227752,"marketCap":6323708872},{"date":"2023-09-15","current":-3.276331,"twenty":-12.381613,"median":-10.935179,"eighty":-6.512762,"marketCap":6855751685},{"date":"2023-09-22","current":-3.006155,"twenty":-12.36402,"median":-10.844647,"eighty":-3.792803,"marketCap":6262903979},{"date":"2023-09-29","current":-2.913601,"twenty":-12.34839,"median":-10.788114,"eighty":-3.305013,"marketCap":6080489300},{"date":"2023-10-06","current":-3.060747,"twenty":-12.287596,"median":-10.741943,"eighty":-3.213384,"marketCap":6384513765},{"date":"2023-10-13","current":-3.036132,"twenty":-12.066426,"median":-10.551151,"eighty":-3.148051,"marketCap":6323708872},{"date":"2023-10-20","current":-3.106604,"twenty":-11.932534,"median":-10.469238,"eighty":-3.120451,"marketCap":6460519881},{"date":"2023-10-27","current":-2.925118,"twenty":-11.796455,"median":-10.343076,"eighty":-3.068613,"marketCap":6080489300},{"date":"2023-11-03","current":-2.990305,"twenty":-11.691357,"median":-10.218458,"eighty":-3.045502,"marketCap":6232501532},{"date":"2023-11-10","current":-3.268138,"twenty":-11.654904,"median":-9.796084,"eighty":-3.060747,"marketCap":6810148016},{"date":"2023-11-17","current":-3.108791,"twenty":-11.613111,"median":-4.217909,"eighty":-3.060747,"marketCap":6536525997},{"date":"2023-11-24","current":-2.853944,"twenty":-11.467369,"median":-3.800488,"eighty":-3.019641,"marketCap":6050086853},{"date":"2023-12-01","current":-2.756466,"twenty":-11.417592,"median":-3.514265,"eighty":-2.990305,"marketCap":5867672174},{"date":"2023-12-08","current":-2.351787,"twenty":-11.401481,"median":-3.313885,"eighty":-2.93822,"marketCap":4986001226},{"date":"2023-12-15","current":-1.83926,"twenty":-11.309603,"median":-3.276331,"eighty":-2.913601,"marketCap":3921915598},{"date":"2023-12-22","current":-1.398202,"twenty":-11.281516,"median":-3.266894,"eighty":-2.872719,"marketCap":2979439757},{"date":"2023-12-29","current":-1.558248,"twenty":-11.205602,"median":-3.218707,"eighty":-2.860632,"marketCap":3338188625},{"date":"2024-01-05","current":-1.057644,"twenty":-11.154992,"median":-3.21182,"eighty":-2.802771,"marketCap":2249781041},{"date":"2024-01-12","current":-0.999942,"twenty":-11.150782,"median":-3.160184,"eighty":-2.759084,"marketCap":2128171255},{"date":"2024-01-19","current":-0.956974,"twenty":-11.111144,"median":-3.130992,"eighty":-2.490877,"marketCap":2033923670},{"date":"2024-01-26","current":-1.01241,"twenty":-11.026152,"median":-3.120712,"eighty":-2.309623,"marketCap":2143372478},{"date":"2024-02-02","current":-0.936815,"twenty":-10.964346,"median":-3.106604,"eighty":-1.836456,"marketCap":1980801062},{"date":"2024-02-09","current":-0.896369,"twenty":-10.938224,"median":-3.073227,"eighty":-1.544488,"marketCap":1904616406},{"date":"2024-02-16","current":-0.959266,"twenty":-10.919956,"median":-3.067843,"eighty":-1.412953,"marketCap":2038701401},{"date":"2024-02-23","current":-0.899483,"twenty":-10.863612,"median":-3.062215,"eighty":-1.31118,"marketCap":1901569020},{"date":"2024-03-01","current":-1.152465,"twenty":-10.844647,"median":-3.040182,"eighty":-1.17923,"marketCap":2437909000},{"date":"2024-03-08","current":-0.971959,"twenty":-10.843385,"median":-3.012898,"eighty":-1.152465,"marketCap":2056985718},{"date":"2024-03-15","current":-1.145767,"twenty":-10.800615,"median":-3.003359,"eighty":-1.102403,"marketCap":2422672068},{"date":"2024-03-22","current":-1.210287,"twenty":-10.775614,"median":-2.971683,"eighty":-1.108733,"marketCap":2556757063},{"date":"2024-03-28","current":-1.130651,"twenty":-10.768565,"median":-2.94471,"eighty":-1.126268,"marketCap":2404387751},{"date":"2024-04-05","current":-1.018114,"twenty":-10.746915,"median":-2.925118,"eighty":-1.078437,"marketCap":2163644237},{"date":"2024-04-12","current":-1.011803,"twenty":-10.711537,"median":-2.916466,"eighty":-1.052694,"marketCap":2151454692},{"date":"2024-04-19","current":-0.965334,"twenty":-10.642392,"median":-2.906537,"eighty":-1.046989,"marketCap":2050890946},{"date":"2024-04-26","current":-1.03546,"twenty":-10.539635,"median":-2.868164,"eighty":-1.036496,"marketCap":2197165486},{"date":"2024-05-03","current":-1.095099,"twenty":-10.513514,"median":-2.860037,"eighty":-1.038246,"marketCap":2322108322},{"date":"2024-05-10","current":-1.015083,"twenty":-10.47457,"median":-2.807837,"eighty":-1.032578,"marketCap":2157549465},{"date":"2024-05-17","current":-1.060526,"twenty":-10.460353,"median":-2.785798,"eighty":-1.029219,"marketCap":2239828893},{"date":"2024-05-24","current":-1.149726,"twenty":-10.37667,"median":-2.759739,"eighty":-1.030854,"marketCap":2422672068},{"date":"2024-05-31","current":-1.040202,"twenty":-10.309482,"median":-2.716272,"eighty":-1.030854,"marketCap":2194118100},{"date":"2024-06-07","current":-0.954703,"twenty":-10.241692,"median":-2.483148,"eighty":-1.020882,"marketCap":2011274925},{"date":"2024-06-14","current":-0.88753,"twenty":-10.223105,"median":-2.348826,"eighty":-1.015017,"marketCap":1868047771},{"date":"2024-06-21","current":-0.879235,"twenty":-9.893357,"median":-2.097181,"eighty":-1.011704,"marketCap":1846716067},{"date":"2024-06-28","current":-0.930402,"twenty":-9.799284,"median":-1.836923,"eighty":-1.004715,"marketCap":1953374586},{"date":"2024-07-05","current":-0.911731,"twenty":-9.796084,"median":-1.670031,"eighty":-0.989934,"marketCap":1913758565},{"date":"2024-07-12","current":-0.998824,"twenty":-6.512762,"median":-1.535315,"eighty":-0.975822,"marketCap":2099649126},{"date":"2024-07-19","current":-1.078316,"twenty":-4.260297,"median":-1.440488,"eighty":-0.983109,"marketCap":2266795296},{"date":"2024-07-26","current":-1.109957,"twenty":-4.076914,"median":-1.398202,"eighty":-0.988979,"marketCap":2341976752},{"date":"2024-08-02","current":-1.019736,"twenty":-3.896516,"median":-1.341466,"eighty":-0.989934,"marketCap":2150360472},{"date":"2024-08-09","current":-1.088923,"twenty":-3.792803,"median":-1.273961,"eighty":-0.992426,"marketCap":2311561470},{"date":"2024-08-16","current":-1.21024,"twenty":-3.761985,"median":-1.221942,"eighty":-0.996911,"marketCap":2570091371},{"date":"2024-08-23","current":-1.4747,"twenty":-3.613333,"median":-1.260835,"eighty":-0.999495,"marketCap":3144940210},{"date":"2024-08-30","current":-6.768747,"twenty":-3.613333,"median":-1.282548,"eighty":-1.003043,"marketCap":3899239216},{"date":"2024-09-06","current":-6.86048,"twenty":-4.076914,"median":-1.344748,"eighty":-1.005589,"marketCap":3953986725},{"date":"2024-09-13","current":-7.629828,"twenty":-6.773268,"median":-1.399159,"eighty":-1.006459,"marketCap":4385883736},{"date":"2024-09-20","current":-7.679018,"twenty":-6.86048,"median":-1.408171,"eighty":-1.008176,"marketCap":4440631245},{"date":"2024-09-27","current":-8.467696,"twenty":-7.210357,"median":-1.4747,"eighty":-1.010386,"marketCap":4926157965},{"date":"2024-10-04","current":-8.045497,"twenty":-7.438254,"median":-1.528968,"eighty":-1.010794,"marketCap":4659279943},{"date":"2024-10-10","current":-6.916807,"twenty":-7.445917,"median":-1.535454,"eighty":-1.011308,"marketCap":3979699659},{"date":"2024-10-18","current":-6.535297,"twenty":-7.4076,"median":-1.599022,"eighty":-1.011803,"marketCap":3740585295},{"date":"2024-10-25","current":-6.87674,"twenty":-7.395,"median":-1.716627,"eighty":-1.011971,"marketCap":3935766258},{"date":"2024-11-01","current":-6.487355,"twenty":-7.390607,"median":-1.836923,"eighty":-1.01241,"marketCap":3715412316},{"date":"2024-11-08","current":-5.268552,"twenty":-7.067714,"median":-2.097181,"eighty":-1.012524,"marketCap":2994521565},{"date":"2024-11-15","current":-4.934518,"twenty":-6.939983,"median":-2.348826,"eighty":-1.014752,"marketCap":2783467441},{"date":"2024-11-22","current":-4.525008,"twenty":-6.921031,"median":-2.487824,"eighty":-1.015083,"marketCap":2551002028},{"date":"2024-11-29","current":-4.212716,"twenty":-6.916807,"median":-2.719501,"eighty":-1.015704,"marketCap":2373594213},{"date":"2024-12-06","current":-4.301808,"twenty":-6.905598,"median":-2.763011,"eighty":-1.018114,"marketCap":2418082775},{"date":"2024-12-13","current":-4.02776,"twenty":-6.88455,"median":-2.792596,"eighty":-1.019736,"marketCap":2261974665},{"date":"2024-12-20","current":-3.895979,"twenty":-6.880216,"median":-2.853944,"eighty":-1.020882,"marketCap":2175955910},{"date":"2024-12-27","current":-3.693493,"twenty":-6.879252,"median":-2.860037,"eighty":-1.021555,"marketCap":2061264237},{"date":"2025-01-03","current":-3.393321,"twenty":-6.877861,"median":-2.868164,"eighty":-1.023476,"marketCap":1895598486},{"date":"2025-01-10","current":-2.994045,"twenty":-6.870236,"median":-2.906537,"eighty":-1.026058,"marketCap":1666215140},{"date":"2025-01-17","current":-2.591221,"twenty":-6.86048,"median":-2.868164,"eighty":-1.027008,"marketCap":1443203553},{"date":"2025-01-24","current":-2.296545,"twenty":-6.833199,"median":-2.860899,"eighty":-1.028243,"marketCap":1287095443},{"date":"2025-01-28","current":-2.466671,"twenty":-6.805918,"median":-2.857066,"eighty":-1.028894,"marketCap":1389043597},{"date":"2025-02-07","current":-2.798033,"twenty":-6.785996,"median":-2.820002,"eighty":-1.030527,"marketCap":1567452866},{"date":"2025-02-14","current":-3.403301,"twenty":-6.780924,"median":-2.832166,"eighty":-1.031664,"marketCap":1901970246},{"date":"2025-02-21","current":-2.965189,"twenty":-6.771007,"median":-2.858982,"eighty":-1.034711,"marketCap":1666215140},{"date":"2025-02-28","current":-3.128579,"twenty":-6.737748,"median":-2.857066,"eighty":-1.035452,"marketCap":1752233895},{"date":"2025-03-07","current":-3.795937,"twenty":-6.685693,"median":-2.863309,"eighty":-1.035834,"marketCap":2134539472},{"date":"2025-03-14","current":-3.17157,"twenty":-6.632156,"median":-2.878989,"eighty":-1.03679,"marketCap":1784092693},{"date":"2025-03-21","current":-3.342788,"twenty":-6.586773,"median":-2.907899,"eighty":-1.03784,"marketCap":1879669087},{"date":"2025-03-28","current":-4.261325,"twenty":-6.543854,"median":-2.91933,"eighty":-1.038839,"marketCap":1978431362},{"date":"2025-04-03","current":-3.930581,"twenty":-6.51804,"median":-2.925118,"eighty":-1.039278,"marketCap":1825509131},{"date":"2025-04-11","current":-3.073189,"twenty":-6.495027,"median":-2.922242,"eighty":-1.03967,"marketCap":1414530635},{"date":"2025-04-17","current":-3.165897,"twenty":-6.47136,"median":-2.94471,"eighty":-1.039975,"marketCap":1459132952},{"date":"2025-04-25","current":-3.918674,"twenty":-6.44197,"median":-2.955046,"eighty":-1.041501,"marketCap":1809579732},{"date":"2025-05-02","current":-4.151319,"twenty":-6.420376,"median":-2.965975,"eighty":-1.046698,"marketCap":1921085525},{"date":"2025-05-09","current":-4.238599,"twenty":-6.416374,"median":-2.989735,"eighty":-1.04728,"marketCap":1975245482},{"date":"2025-05-16","current":-4.366995,"twenty":-6.405055,"median":-3.003359,"eighty":-1.048429,"marketCap":2051706597},{"date":"2025-05-23","current":-5.848115,"twenty":-6.313401,"median":-3.007935,"eighty":-1.050731,"marketCap":2755786035},{"date":"2025-05-30","current":-6.515833,"twenty":-6.416374,"median":-3.036132,"eighty":-1.051354,"marketCap":3083931656},{"date":"2025-06-06","current":-6.996095,"twenty":-6.508395,"median":-3.039313,"eighty":-1.052,"marketCap":3319686762},{"date":"2025-06-13","current":-8.228236,"twenty":-6.545559,"median":-3.060747,"eighty":-1.052348,"marketCap":3905888647},{"date":"2025-06-20","current":-6.374949,"twenty":-6.632156,"median":-3.067399,"eighty":-1.052744,"marketCap":3020214059},{"date":"2025-06-27","current":-6.3035,"twenty":-6.639184,"median":-3.073189,"eighty":-1.053079,"marketCap":2994727021},{"date":"2025-07-04","current":-5.954515,"twenty":-6.641618,"median":-3.086246,"eighty":-1.054062,"marketCap":2829061271},{"date":"2025-07-11","current":-5.819562,"twenty":-6.627625,"median":-3.114534,"eighty":-1.055579,"marketCap":2762157795},{"date":"2025-07-18","current":-6.720769,"twenty":-6.641618,"median":-3.123457,"eighty":-1.057059,"marketCap":3187401188},{"date":"2025-07-25","current":-6.141724,"twenty":-6.627625,"median":-3.129786,"eighty":-1.059373,"marketCap":2923374942},{"date":"2025-08-01","current":-5.729361,"twenty":-6.595465,"median":-3.139962,"eighty":-1.061686,"marketCap":2710245321},{"date":"2025-08-08","current":-5.735189,"twenty":-6.557071,"median":-3.15919,"eighty":-1.06292,"marketCap":2719788439},{"date":"2025-08-15","current":-6.274508,"twenty":-6.540468,"median":-3.165897,"eighty":-1.063408,"marketCap":2971090528},{"date":"2025-08-22","current":-6.442504,"twenty":-6.540468,"median":-3.175987,"eighty":-1.065225,"marketCap":3041073389},{"date":"2025-08-29","current":-7.115719,"twenty":-6.557071,"median":-3.21131,"eighty":-1.067861,"marketCap":3674100172},{"date":"2025-09-05","current":-7.091352,"twenty":-6.584214,"median":-3.213297,"eighty":-1.074535,"marketCap":3657890365},{"date":"2025-09-08","current":-6.964645,"twenty":-6.599039,"median":-3.214541,"eighty":-1.076426,"marketCap":3595183673}],"updateTime":1757435861825},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02487\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148579356","title":"CUTIA-B (02487) Shareholders Deposit Shares with Huatai Hong Kong Worth HK$286 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1148579356","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148579356?lang=en_us&edition=fundamental","pubTime":"2025-09-08 08:24","pubTimestamp":1757291054,"startTime":"0","endTime":"0","summary":"According to the latest information from the Hong Kong Stock Exchange, on September 5, CUTIA-B (02487) shareholders deposited shares with Huatai Hong Kong, with a custody market value of HK$286...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2565553761","title":"Cutia Therapeutics Completes Successful Private Placement of New Shares, Raising Funds from Key Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2565553761","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565553761?lang=en_us&edition=fundamental","pubTime":"2025-09-05 16:46","pubTimestamp":1757062018,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics has successfully completed a private placement of new shares under a general mandate. The company announced that a total of 28,904,000 placing shares were successfully placed by the Placing Agents to TruMed Health Innovation Fund LP, Octagon Investments Master Fund LP, and Octagon Private Opportunities Fund II LP at a placing price of HK$8.40 per share. TruMed, an exempted limited partnership incorporated in the Cayman Islands, is a pooled investment fund primarily investing in healthcare equities. This completion marks a significant step for Cutia Therapeutics in raising capital to support its endeavors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDL4t4GgP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"1197721299","title":"CUTIA-B (02487) Completes Placement of 28.904 Million Shares, Raising Net Proceeds of Approximately HK$240 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1197721299","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197721299?lang=en_us&edition=fundamental","pubTime":"2025-09-05 16:38","pubTimestamp":1757061496,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced that the share placement was completed on September 5, 2025, in accordance with the terms and conditions of the placement agreement. The placement agents successfully placed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2563172480","title":"Hong Kong Stocks End in Green Friday as Earnings Flurry Continues; Cutia Therapeutics Seeking HK$240.3 Million via Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2563172480","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563172480?lang=en_us&edition=fundamental","pubTime":"2025-08-29 16:43","pubTimestamp":1756456992,"startTime":"0","endTime":"0","summary":"Hong Kong stocks reversed their downward slide Friday as markets analyzed the latest batch of earnings.The Hang Seng Index gained 78.80 points, or 0.32%, to 25,077.62, while the Hang Seng China Enterprises Index rose 30.86 points, or 0.35%, to 8,947.79.Among the firms reporting earnings, Haier Smart Home  saw its profit come ahead of expectations. The home appliances company reported 1.29 yuan in earnings per share on revenue of 156.5 billion yuan, compared to the Visible Alpha estimate of 1.20 yuan on sales of 151.9 billion yuan.Meanwhile, Chinese traditional medicines company Gushengtang  reported results that fell short of expectations. The firm reported earnings of 0.62 yuan per share on revenue of 1.49 billion yuan, compared to the Visible Alpha estimate of 0.67 yuan on sales of 1.63 billion yuan.Major Chinese firms Alibaba Group  and Industrial and Commercial Bank of China  are due to report earnings next week with investors reportedly expecting higher profits.In corporate news, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HSI","06690","02487","LENZ","02273","01398"],"gpt_icon":1},{"id":"1183779957","title":"HK Movers | Biotech Stocks Surge With Cutia Therapeutics up 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183779957","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183779957?lang=en_us&edition=fundamental","pubTime":"2025-08-29 10:38","pubTimestamp":1756435121,"startTime":"0","endTime":"0","summary":"Biotech stocks surged in Hong Kong on Friday. Cutia Therapeutics rose 14%; Antengene rose 13%; HBM Holdings and TransThera Sciences rose 9%; RemeGen rose 8%; CARsgen Therapeutics rose 7%; WuXi...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5f33b3b5eefd72d982b2d94c09297262","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","09995","06996","02617","02171","02487","02142"],"gpt_icon":0},{"id":"1129795454","title":"Stock Track | Cutia Therapeutics Soars 5.34% Pre-market Following HK$240 Million Share Placing Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129795454","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129795454?lang=en_us&edition=fundamental","pubTime":"2025-08-29 09:40","pubTimestamp":1756431641,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics (CUTIA-B) saw its stock price surge 5.34% in pre-market trading on Friday, following the company's announcement of a significant share placing. The biopharmaceutical firm revealed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02487"],"gpt_icon":0},{"id":"1130812092","title":"CUTIA-B (02487) Plans to Issue 28.904 Million Placement Shares at 12.04% Discount, Raising Net Proceeds of HK$240 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1130812092","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130812092?lang=en_us&edition=fundamental","pubTime":"2025-08-29 07:18","pubTimestamp":1756423096,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced that on August 28, 2025, the company entered into placement agreements with various placing agents. The placing agents have agreed to act as placing agents to procure...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2563067036","title":"Cutia Therapeutics -  Placing of 28.9 Mln Shares in Aggregate at a Price of HK$8.40 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2563067036","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563067036?lang=en_us&edition=fundamental","pubTime":"2025-08-29 07:11","pubTimestamp":1756422667,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UK1SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2563032067","title":"Cutia Therapeutics Announces Placing of 28.9 Million New Shares Under General Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=2563032067","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563032067?lang=en_us&edition=fundamental","pubTime":"2025-08-29 07:10","pubTimestamp":1756422637,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics has entered into Placing Agreements with Placing Agents to procure placees for a total of 28,904,000 shares at a price of HK$8.40 per share. This transaction, representing approximately 9.05% of the issued shares of the company, is expected to generate net proceeds of approximately HK$240.26 million after deducting related fees and expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL6vNqMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"1181956085","title":"CUTIA-B (02487): Zhang Zhisong Appointed as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1181956085","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181956085?lang=en_us&edition=fundamental","pubTime":"2025-08-28 17:00","pubTimestamp":1756371620,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced that Mr. Tao Deren has resigned from his positions as independent non-executive director, member of the board audit committee, and member of the board nomination committee,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"1151119822","title":"CUTIA-B (02487): Liang Zhijie Appointed as Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1151119822","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151119822?lang=en_us&edition=fundamental","pubTime":"2025-08-28 17:00","pubTimestamp":1756371617,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced that Ms. Chen Shiting has submitted her resignation letter, stepping down from her positions as (1) company secretary, (2) authorized representative, and (3) process agent,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"1100341156","title":"CUTIA-B (02487) Announces Interim Results with Net Loss of Approximately 239 Million Yuan, Up About 19.1% Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1100341156","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100341156?lang=en_us&edition=fundamental","pubTime":"2025-08-28 16:54","pubTimestamp":1756371293,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced its 2025 interim results, with revenue decreasing 30.6% year-over-year to approximately 66.3 million yuan, and gross profit of approximately 32.1 million yuan, down 36.3%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2562703089","title":"Cutia Therapeutics Announces Management Changes and Relocation of Hong Kong Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2562703089","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562703089?lang=en_us&edition=fundamental","pubTime":"2025-08-28 16:48","pubTimestamp":1756370899,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics has announced changes in its management, effective 28 August 2025. Ms. Chan Sze Ting has resigned from her roles as company secretary, authorised representative, and process agent. Mr. Leung has been appointed as the new company secretary. Additionally, the company's principal place of business in Hong Kong has been relocated to 31/F, Tower Two, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL7lpg33:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2562089274","title":"Cutia Therapeutics Announces Management Changes: New Appointments to Nomination and Audit Committees as Mr. Tao Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2562089274","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562089274?lang=en_us&edition=fundamental","pubTime":"2025-08-28 16:41","pubTimestamp":1756370499,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics has announced changes in its board of directors effective from August 28, 2025. Mr. Tao Tak Yan Dennis has resigned as an independent non-executive director, as well as a member of the audit and nomination committees, to focus on personal commitments. The board now includes Mr. Zhang as a new independent non-executive director. The changes aim to enhance diversity and improve decision-making within the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL7zCVsC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2562089345","title":"Cutia Therapeutics -  Hy Revenue RMB66.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562089345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562089345?lang=en_us&edition=fundamental","pubTime":"2025-08-28 16:33","pubTimestamp":1756370029,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UJ17Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2556680692","title":"Cutia Therapeutics Gets Hong Kong Government Nod to Market Alopecia Drug; Shares Up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556680692","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556680692?lang=en_us&edition=fundamental","pubTime":"2025-08-04 15:53","pubTimestamp":1754294004,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics  obtained marketing approval for topical finasteride spray CU-40102 from the Hong Kong government's Department of Health for the treatment of androgenetic alopecia, an Aug. 1 Hong Kong bourse filing said.Shares of the firm rose over 2% in Monday afternoon trade.The drug has already obtained approval from China's National Medical Products Administration.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","02487","BK4139","BK4007","BK4539","BK1161"],"gpt_icon":0},{"id":"2556544892","title":"BRIEF-Cutia Therapeutics Says Cu-40102 Obtains Marketing Approval By Hong Kong Department Of Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2556544892","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556544892?lang=en_us&edition=fundamental","pubTime":"2025-08-01 18:30","pubTimestamp":1754044215,"startTime":"0","endTime":"0","summary":"BRIEF-Cutia Therapeutics Says Cu-40102 Obtains Marketing Approval By Hong Kong Department Of HealthAug 1 (Reuters) - Cutia Therapeutics 2487.HK:CU-40102 OBTAINS MARKETING APPROVAL BY HONG KONG DEPARTMENT OF HEALTHFurther company coverage: 2487.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2556894307","title":"Cutia Therapeutics - Cu-40102 Obtains Marketing Approval by Hong Kong Department of Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2556894307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556894307?lang=en_us&edition=fundamental","pubTime":"2025-08-01 18:18","pubTimestamp":1754043507,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2547904064","title":"Cutia Therapeutics Secures Regulatory Approval for CU-40102 Topical Finasteride Spray by China's National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2547904064","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547904064?lang=en_us&edition=fundamental","pubTime":"2025-06-30 17:24","pubTimestamp":1751275465,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics Secures Regulatory Approval for CU-40102 Topical Finasteride Spray by China's National Medical Products Administration. Cutia Therapeutics has announced that its CU-40102  has obtained marketing approval from the National Medical Products Administration  of China. This product is approved for the treatment of androgenetic alopecia and is notable for being the first and only topical finasteride product approved globally for this condition, as well as the first approved for marketing in China. The approval strengthens Cutia Therapeutics' presence in the dermatology treatment sector, following its earlier product approval for CU-10201 . A New Drug Application for CU-40102 has also been submitted to the Department of Health in Hong Kong. However, the company advises caution to shareholders and potential investors as there is no assurance of the product's successful market performance.Disclaimer: This news brief was created by Public Technologies  using generative artific","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDLbhZS2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2546754735","title":"Cutia Therapeutics' CU-30101 Marketing Authorization Application Accepted by National Medical Products Administration for Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2546754735","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546754735?lang=en_us&edition=fundamental","pubTime":"2025-06-27 06:07","pubTimestamp":1750975634,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics' CU-30101 Marketing Authorization Application Accepted by National Medical Products Administration for Review. Cutia Therapeutics has announced the acceptance of their drug marketing authorization application for CU-30101 by the National Medical Products Administration in July 2024. This follows the successful completion of a Phase III clinical trial for CU-30101, a localized topical lidocaine and tetracaine cream designed for topical anesthesia operations. The trial results have been recognized for presentation at the 30th Annual Meeting of the Chinese Society of Dermatology, highlighting the company's influence and advanced standing in dermatology. There is no assurance, however, that CU-30101 will be successfully marketed, and stakeholders are advised to exercise caution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL40sdrl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}